UPenn Scientists, Regeneron Developing Nasal Spray to Prevent COVID-19 Infections

UPenn Scientists, Regeneron Developing Nasal Spray to Prevent COVID-19 Infections

A nasal spray is being eyed for a possible development to prevent COVID-19 infections.
New York Lab Tests Serum From Recovered COVID-19 Patients For Possible Therapy

FDA Grants Emergency Use Approval for Regeneron COVID-19 Treatment, But There's a Catch

By D. Cruz
The U.S. Food and Drug Administration (FDA) granted on Saturday an emergency use authorization for Regeneron's COVID-19 antibody treatment.
Regeneron Stops Trial of Antibody Drug for Severely Ill Covid-19 Patients

Regeneron Stops Trial of Antibody Drug for Severely Ill COVID-19 Patients

By Madelaine D.
Regeneron Pharmaceuticals has paused a clinical trial of its experimental antibody drug for seriously ill COVID-19 patients because of a potential safety concern.
Regeneron CEO Says US Gov’t Secured 300k Doses With $450 Million Contract

Regeneron CEO Says US Gov't Secured 300k Doses With $450 Million Contract

By Mary Anne R.
Regeneron CEO Leonard Schleifer said that US government has managed to secure around 300,000 doses of the antibody cocktail through a $450 million contract.
Most Read
  1. Maite Perroni's Relationship with Anahí & Dulce María Is Seemingly Strained
  2. Ángela Aguilar Booed at the Kids Choice Awards
Real Time Analytics